Go-To-Market Strategy · Life Sciences & B2B SaaS

The strategist who says what your last agency wouldn't.

When growth stalls, the easy answer is “fix marketing.” Usually the real problem is upstream — the company changed and the go-to-market didn't. I find the gap, rebuild the position, and turn your market's highest-stakes moment into a demand engine your team owns. Not a campaign — a system.

Book a Strategy Call → See the Proof
Flagship · J.P. Morgan Healthcare Conference
$1.2M

Pipeline generated in a single week for a healthcare-intelligence leader — now repeatable every year.

814
Form submissions
106
Demo requests
13%
MQL conversion
The Real Problem

When Growth Stalls, Marketing Gets the Blame

The reflex is to spend more — more campaigns, more tools, more outbound. But effort is rarely the issue. The company became something its go-to-market no longer describes: a pivot, a raise, a new product, a new buyer. The story, the targeting, and the way the teams work never caught up.

When those drift apart, work stops compounding. Marketing drives leads sales doesn't want. Sales chases deals that don't close. You can't campaign your way out of that — and the fix starts before the next dollar of spend.

What's actually broken is the connection between:
What the company is nowproduct · buyer · stage
How it shows uppositioning · messaging · targeting
How its teams executeownership · handoffs · incentives
How I Work

I Build Systems, Not Campaigns

Three convictions separate a one-time win from an asset the business keeps long after the engagement ends.

01

Position Before Spend

The leverage is in the point of view — who you're for and why it matters — long before the first dollar of media. Get that right and everything downstream compounds.

02

Own the Decisive Moment

Every market has a few moments where attention and budget concentrate. Owning one end to end beats being present at all of them.

03

Leave a Capability Behind

The deliverable isn't a campaign — it's a repeatable system your in-house team keeps running for years after I'm gone.

Flagship · J.P. Morgan Healthcare Conference

The Industry's Biggest Week, Owned by No One

Every January, J.P. Morgan concentrates healthcare's capital, dealmaking, and attention into a single week — the highest-intent buying window of the year for an intelligence company, and it was being left on the table. We claimed the category position for the moment, then engineered a demand architecture designed to run again every year, not once.

$1.2M
Pipeline Revenue
814
Form Submissions
106
Demo / Call-Back Requests
13%
MQL Conversion

~$133K average value across 9 opportunities — generated in one week, now repeatable every year.

What You Keep

The Real Deliverable Is a Capability

When the engagement ends, the campaign isn't what stays. An owned system is — one your team re-runs every year, with no re-discovery and no agency dependency.

A Defensible Position

An ownable claim on your industry's defining moment.

A Buyer Architecture

Segmented, prioritized audiences with clear intent.

A Channel Playbook

The full orchestration, ready to run again.

A Measurement Model

Activity tied directly to pipeline and revenue.

How We Work Together

Three Ways In

Most relationships start with the diagnosis. What follows is scoped to what it finds — and built to be owned by your team, not rented from me.

01
Position Before Spend

The Diagnostic

A fixed-scope engagement that finds where your company and your go-to-market have drifted apart — across positioning, structure, and execution — and returns the finding plus a realignment plan. The front door to everything below.

02
Build the System

The Core Engagement

Revenue architecture and the infrastructure that converts it — positioning, pipeline model, messaging, and the systems to run them. Scoped to what the diagnostic finds, and built to be owned by your team.

03
Leave a Capability Behind

Orchestrated Build & Oversight

I architect the system and oversee delivery — directing your team and the specialists who execute — so the work ships at standard and the capability stays in-house. Strategic partnership through the build, not a permanent pair of hands.

Talk Through the Right Fit →
Who It's For

Growth-Stage Life Sciences and B2B SaaS

This works best for companies past founder-led selling — a real sales team, a real funnel, real data — where growth has stalled and another campaign hasn't fixed it. In life sciences (biopharma, diagnostics, data and tech), the credibility is immediate. In B2B SaaS, the diagnosis is the differentiator: the same method, applied where an outside read on positioning and go-to-market is the edge.

If you're pre-funnel or still founder-led, you likely need more data before a diagnosis pays off. I'll still be here when you do.

Ashley Peoples, Founder of Ignite Your Spark Digital
About

The Strategist Behind the System

I'm Ashley Peoples. For more than a decade I led digital marketing and communications inside Fortune 500 healthcare and biopharma — close enough to the work to learn that the most brilliant strategy means nothing if it never connects to how the company actually operates.

I built the engine that turned J.P. Morgan week into $1.2M in pipeline for a leading healthcare-intelligence company. I work as a strategic partner to leadership — from the diagnosis through the build — and I leave a system your team can run without me.

— Ashley Peoples, Founder, Ignite Your Spark Digital

Let's build the system behind your next win.

If growth has stalled and “marketing” is the easy answer, it's worth pressure-testing whether it's the real one. It rarely is.

Book a Strategy Call →